Astrum

Astrum is a pan-European mid-sized Contract Research Organization launched in 2023 via the merger of four established European CROs—BlueClinical, Pharmalog, Popsicube, and Bioclever—with support from Henko Partners. It offers comprehensive clinical development services across the entire drug development lifecycle. The company operates hospital-based Phase I units and supports trials up to Phase IV/NIS. With over 300 employees across major European cities and more than 25 years of combined experience among its constituent companies, Astrum is positioned as an agile partner for pharmaceutical and biotech clients seeking end-to-end or tailored clinical trial solutions in Europe.